Cell and gene therapy companies must demonstrate strong value proposition for investment
Investment for companies developing cell and gene therapies (CGTs) was discussed during the GenScript Biotech Global Forum London 2024 conference …
Post
-
-
Eli Lilly to invest $3bn in Wisconsin facility expansion
Eli Lilly has announced a $3bn investment to expand its newly acquired manufacturing facility in Kenosha County, Wisconsin, US, which …
-
Centenarians – unlocking the secrets of living to 100
The concept of extremely long life, popularised in films like Highlander, may seem like pure fiction, however; researchers are actively …
-
Muna-GSK alliance to fast-track Alzheimer’s disease treatments
Muna Therapeutics has entered a research alliance with GSK to expedite Alzheimer's disease treatments by discovering and validating new drug …
-
FDA ARMAT status for Affimed and Artiva’s lymphoma combo therapy
The US Food and Drug Administration (FDA) has granted regenerative medicine advanced therapy (RMAT) designation to Affimed and Artiva Biotherapeutics’ …
-
Merus’ Bizengri granted FDA accelerated approval to treat NRG1+ cancers
Merus’ Bizengri (zenocutuzumab-zbco) has received accelerated approval from the US Food and Drug Administration (FDA), marking “an important milestone” in …
-
Dewpoint Therapeutics and Mitsubishi Tanabe link on ALS treatment
Dewpoint Therapeutics and Mitsubishi Tanabe Pharma Corporation (MTPC) have entered a strategic research partnership focusing on the development of the …
-
LEO Pharma’s eczema cream gains MHRA marketing authorisation
LEO Pharma has gained marketing authorisation from the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) for its topical pan-Janus …
-
FDA approves AstraZeneca’s Imfinzi to treat LS-SCLC
The US Food and Drug Administration (FDA) has approved AstraZeneca's human monoclonal antibody, Imfinzi (durvalumab), to treat limited-stage small cell …
-
CEO of UnitedHealthcare, Brian Thompson, shot dead in New York City
The CEO of US healthcare insurance firm UnitedHealthcare Group has been shot dead by a masked gunman outside of the …
-
Lilly’s Zepbound wins the weight loss duel with Novo’s Wegovy
Eli Lilly has scored a win in the ongoing competition with Novo Nordisk in the obesity space, as a Phase …
-
Maze Therapeutics raises $115m to advance kidney disease candidates
Maze Therapeutics has completed a Series D financing round, raising $115m to propel the development of its lead candidates, MZE829 …
-
Ipsen and Biomunex enter agreement for cancer therapy
Ipsen has entered an exclusive worldwide licensing agreement with Biomunex Pharmaceuticals for BMX-502, a first-in-class bispecific antibody designed to engage …
-
Takeda licensed for anaemia therapy by Keros Therapeutics
Takeda has agreed to receive an exclusive global licence from Keros Therapeutics to advance the development, manufacture and commercialisation of …
-
All-in-one milling platforms: How to reduce your machinery footprint
The pharmaceutical industry is currently experiencing a surge in novel drug candidates. These new drug approvals are leading to a …
